Takeda, Par, Watson, Amneal accused of keeping out anti-inflammatory drug Colcrys competitors
MLex Summary: Takeda Pharmaceuticals, Endo Pharmaceuticals, Amneal Pharmaceuticals, Teva Pharmaceutical, and Par Pharmaceutical have been accused of conspiring to limit competition to Takeda’s branded and ‘authorized generic’ anti-inflammatory drug Colcrys. According to...To view the full article, register now.
Already a subscriber? Click here to view full article